Sarah Ford | February 9, 2015
Research progress report: Frizzled 9 and lung cancer chemoprevention
Every year, lung cancer leads to more deaths than any other cancer. An estimated 159,2601 Americans were expected to die from lung cancer in 2014, accounting for about 27% of all cancer deaths.
The Foundation is committed to lung cancer prevention research and currently supports five researchers studying different aspects of preventing this deadly disease. One of these researchers is Meredith Tennis, Ph.D., of the University of Colorado Denver. Her project focuses on Frizzled 9, a protein that helps to maintain normal lung tissue, as a potential biomarker2 to predict how patients may respond to the drug iloprost, a drug being used for chemoprevention.
Get Resources and Insights Straight To Your Inbox
Explore More Articles
Make the Holidays More Meaningful: Engage Your Team with Employee Giving Technology
The holiday season is a time for connection, gratitude, and giving back. For employers, it’s also an ideal moment to strengthen workplace culture, deepen employee…
Read Article
Launch a Turnkey Holiday Giving Campaign
Sign up by October 3, 2025 to launch your employee donation site in time for the holidays! Give employees a simple, meaningful way to make…
Read Article
Data Processor & Customer Service Representative, Charitable Funds Management Solutions
Reporting Structure: Director, CFMS Term: October 2025 to February 2026 Schedule: Full-Time; Monday-Friday up to 37.5 hours per week. Rate: $20 per hour Overview of…
Read ArticleGet Resources and Insights Straight To Your Inbox
Receive our monthly/bi-monthly newsletter filled with information about causes, nonprofit impact, and topics important for corporate social responsibility and employee engagement professionals, including disaster response, workplace giving, matching gifts, employee assistance funds, volunteering, scholarship award program management, grantmaking, and other philanthropic initiatives.
